Patrick A. Baeuerle, Executive Partner at MPM Capital, Cambridge, MA — verified investor profile. See sector focus and contact routes.
Patrick A. Baeuerle serves as an Executive Partner and Managing Director at MPM Capital, a Cambridge-based venture capital firm focused on biotechnology, having joined the firm in April 2015 after a career as a molecular biologist and immunologist at Amgen and Micromet. His investment thesis centers on oncology and immunology, leveraging his deep scientific expertise to support companies developing novel antibody therapies and T-cell engagers across the United States and Europe. While specific check sizes and lead/follow behavior are not publicly detailed, Baeuerle has directly started six companies with MPM Capital since joining, indicating a hands-on, entrepreneurial approach to investing. Notable portfolio companies he has co-founded or advised include Harpoon Therapeutics, Werewolf Therapeutics, TCR2 Therapeutics, and Aktis Oncology, all of which focus on innovative cancer treatments. Baeuerle distinguishes himself by combining over 240 peer-reviewed research papers with practical biopharmaceutical entrepreneurship, notably contributing to the development of the antibody drug Blincyto®. He also serves on the investment committee of the UBS Oncol
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Cambridge.
Investors like Patrick A. Baeuerle · Full investor directory · Investor access · Company funding database